Re: FDA to hear public - special health issues (AMALGAM) 12/13 - Wash.,DC

[Guest guest]

> MERCURY FREE PRESS

> Freya B. Koss

> FreKoss@...

>

> December 8, 2000

>

> FIRST TIME

>

> PUBLIC OPPORTUNITY TO ADDRESS

> THE AMALGAM ISSUE WITH FDA DIRECTORS

>

> LIVE IN THE WASHINGTON, DC, MARYLAND, NEW YORK, NEW JERSEY , DELAWARE

> AREAS.......

> ATTEND THE MEETING AND BE HEARD!

>

> For further information call:

>

> The public will have an opportunity to express their concerns during the

> meeting from 9 - 4 p.m.

>

> OUT OF TOWN: If you haven't submitted your story previously, e-mail to

> Freya at:

> FreKoss@...,

> SUBJECT: FDA ROUNDTABLE - My Story

>

> All stories will be submitted.

>

> FDA Consumer Roundtable on Consumer Protection Priorities

> Wednesday - December 13, 2000

>

> See Agenda below:

>

> Consumer Protection Priorities

>

> The FDA Consumer Roundtable is a first-time effort to bring FDA's

executive

> leadership together with consumer leaders to discuss consumer protection

> priorities. This roundtable is intended to strengthen consumer involvement

in

> the Agency's process for assessing how it is currently directing its

consumer

> protection responsibilities and determining whether there is a need to

> redirect or shift priorities to better meet its consumer protection

> responsibilities. During this discussion, the Agency will present

information

> on its current consumer protection priorities related to its statutory

> responsibilities and dialogue with consumers about their views and

> expectations related to these priorities.

>

>

-----------------------------------------------------------------------------

> ---

>

> AGENDA

>

> FDA Consumer Roundtable on Consumer Protection Priorities

> December 13, 2000

>

> 9:00 - 9:15 Opening

>

> Jane E. Henney, M.D.

> Commissioner of Food and Drugs

>

> Moderator Mark Barnett

>

>

> 9:15 - 10:00 Center for Devices and Radiological Health

> (Dental Devices within this agency)

>

> al, M.D., Director

>

> Lead Respondent Opening Consumer Dialogue

> Lee , Ph.D., Consumer Federation of America

>

> 10:00 - 10:45 Center for Biologics Evaluation and Research

>

> Zoon, Ph.D., Director

>

> Lead Respondent Opening Consumer Dialogue

> Arthur Levin, Center for Medical Consumers

>

> 10:45 - 11:00 Break

> 11:00 - 11:45 Center for Food Safety and Applied Nutrition

>

> ph A. Levitt, Director

>

> Lead Respondent Opening Consumer Dialogue

> son, Ph.D., Center for Science in the Public Interest

>

> 11:45 - 12:30 Center for Veterinary Medicine

>

> Sundlof, DVM, Ph.D., Director

>

> Lead Respondent Opening Consumer Dialogue

> Wood, M.Div., D. Min., Food Animal Concerns Trust

>

> 12:30 - 1:30 Lunch

>

> 1:30 - 2:15 Center for Drug Evaluation and Research

>

> Janet Woodcock, M.D., Director

>

> Lead Respondent Opening Consumer Dialogue

> Pearson, National Womens Health Network

>

> 2:15 3:00 Openness and Transparency

>

> Margaret Jane Porter, Chief Counsel

> Sharon Holston, Deputy Commissioner

> for International and Constituent Relations

>

> Lead Respondent Opening Consumer Dialogue

> Zieve, Public Citizen for Health Research Group

>

> 3:00 - 3:30 Next Steps

>

> Jane E. Henney, M.D.

> Margaret Jane Porter

> Sharon Holston

> Center Directors

>

>

>

-----------------------------------------------------------------------------

> ---

> The Food and Drug Administration continually strives to establish an

> ongoing dialogue between the Agency and its constituents on important

public

> health problems and issues. In 1997, for the first time in history,

Congress

> codified FDA's mission statement into law with the enactment of the Food

and

> Drug Administration Modernization Act of 1997. This new mission not only

> addresses specific public health responsibilities such as those relating to

> food and drug safety, but also emphasizes the manner in which those

> responsibilities will be carried out, such as collaboration with consumers,

> manufacturers, importers and retailers of regulated products.